Last reviewed · How we verify
NCT03472911
Retroclavicular Approach to Infraclavicular Block
trial testing minimum effective volume in Bupivacaine in 25 participants. Completed in 15 March 2018.
1 March 2018
Quick facts
| Lead sponsor | Antalya Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 8 January 2018 |
| Primary completion | 1 March 2018 |
| Estimated completion | 15 March 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- minimum effective volume
Conditions studied
- Bupivacaine — all drugs for Bupivacaine →
Sponsor
Antalya Training and Research Hospital
Who can join
Adults 18 to 65, any sex, with Bupivacaine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the primary objective was to estimate the minimum effective volume of bupivacaine 0.5% resulting in successful block in 50% of patients (MEV50) for ultrasound-guided retroclavicular approach to infraclavicular brachial plexus block.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
[Minimum effective volume of bupivacaine 0.5% for ultrasound-guided retroclavicular approach to infraclavicular brachial plexus block].
Kavakli AS, Kavrut Ozturk N, Arslan U. · · 2019 · cited 4× · PMID 31030903 · DOI 10.1016/j.bjan.2018.11.011
Verify or expand the search:
- PubMed search for NCT03472911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of minimum effective volume
Trials testing the same drug.
- NCT03555786 — MEV for Retroclavicular Approach to Infraclavicular Block · terminated
Other recruiting trials for Bupivacaine
Currently open trials in the same condition.
- NCT07386327 — Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes · NA · recruiting
- NCT07276867 — Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia f · NA · recruiting
- NCT06993922 — Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management · NA · recruiting
- NCT07522736 — Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery · NA · recruiting
- NCT05824338 — Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery · EARLY_PHASE1 · recruiting
Other Antalya Training and Research Hospital trials
Trials by the same sponsor.
- NCT07480811 — The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD · NA · not yet recruiting
- NCT07453615 — Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children · NA · recruiting
- NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
- NCT07524933 — Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome. · NA · active not recruiting
- NCT07497295 — Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypoten · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03472911 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Antalya Training and Research Hospital
- Last refreshed: 3 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03472911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing